98%
921
2 minutes
20
Background: There may be variability in willingness to perform percutaneous coronary intervention (PCI) in higher-risk patients who present with ST-segment-elevation myocardial infarction (STEMI). We sought to describe current treatment selection patterns and hospital-level variability.
Methods And Results: We identified patients presenting with STEMI with a culprit lesion on coronary angiography between January 1, 2019, and March 31, 2023, using the NCDR (National Cardiovascular Data Registry) CPMI (Chest Pain-Myocardial Infarction) registry. We compared patient-level characteristics of patients who did and did not undergo PCI at each hospital. There were 178 984 patients from 582 US hospitals presenting with STEMI who were included. Among patients with STEMI and a culprit lesion, 6180 did not undergo PCI (3.5%). Patients with a presentation of STEMI and a culprit lesion who did not undergo PCI were older (67 [interquartile range, 58-76]) years versus 62 ([interquartile range, 54-71] years, <0.001), more likely to present with heart failure (15.0% versus 7.4%, <0.001), and more likely to have cardiac arrest before arrival (9.7% versus 5.1%, <0.001) than patients who underwent PCI. Patients who did not undergo PCI had higher predicted mortality rates (12.5%±17.9% versus 6.5%±11.5%, <0.001) and observed mortality rates (21.7% versus 6.4%, <0.001) compared with patients who underwent PCI.
Conclusions: There is variability in the percentage of patients with culprit lesions on invasive coronary angiography undergoing PCI for STEMI, with 3.5% of patients with STEMI not receiving PCI overall, and >5% of patients not undergoing PCI in a quarter of US hospitals. Differences in observed versus predicted mortality rates for patients who did or did not undergo PCI may highlight the effects of risk-avoidant behavior.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12132723 | PMC |
http://dx.doi.org/10.1161/JAHA.124.038317 | DOI Listing |
Clin Res Cardiol
September 2025
Department of (Interventional) Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg-628, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Background: Fractional flow reserve (FFR) for non-culprit lesions (NCLs) in patients with ST-elevation myocardial infarction (STEMI) can be influenced by temporary changes in microvascular resistance. Angiography-derived vessel fractional flow reserve (vFFR) has been tested as a less-invasive alternative.
Aims: The FAST STEMI II study aimed to assess the diagnostic performance of acute-setting vFFR vs.
Lancet
September 2025
Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Chonnam National University, Gwangju, South Korea. Electronic address:
Background: The optimal timing of complete revascularisation for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains unclear. We aimed to assess whether immediate complete revascularisation was non-inferior to staged complete revascularisation during the index admission.
Methods: We conducted an open-label, randomised, non-inferiority trial at 14 hospitals in South Korea.
Eur Heart J Open
July 2025
Institut Cardiovasculaire Paris-Sud, Hôpital Jacques Cartier, Ramsay-Santé, 6 Avenue du Noyer Lambert, Massy 91300, France.
J Med Life
July 2025
Clinic of Cardiology, County Emergency Clinical Hospital, Targu Mureș, Romania.
Atherosclerotic cardiovascular disease remains one of the leading causes of morbidity and mortality worldwide, accounting for approximately 3.9 million deaths annually due to its complications. This single-center, retrospective cohort study included 109 patients who underwent coronary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) between April and July 2022 at the Cardiology Clinic of the County Emergency Clinical Hospital in Targu Mureș, Romania.
View Article and Find Full Text PDFJACC Adv
August 2025
Hennepin Healthcare, Department of Emergency Medicine and University of Minnesota, Minneapolis, MN, USA.
Background: Despite no objective definition, hyperacute T waves (HATW) are recommended by the American College of Cardiology as a STEMI equivalent finding, requiring emergent reperfusion.
Objective: We sought to derive and validate a quantitative definition of HATW.
Methods: We retrospectively evaluated adults with possible ACS across five PCI centers.